ICH Q4B - Annex 7(R2) on "Dissolution Testing" becomes binding in the USA too
In June 2011, the FDA published the Guidance for Industry "Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions - Annex 7(R2) - Dissolution Test General Chapter".
Through its ICH Q4B activities, the Q4B Working Group aims to facilitate - for chosen pharmacopoeial texts - mutual recognition by regulatory authorities in the three ICH regions. Through this, redundant investigations by the pharmaceutical industry should be avoided, too.
The current Annex already presents the second revision of this document. This second revision of Q4B Annex 7 contains specifications about additional apparatuses for Dissolution Testing to which Interchangeability applies in the ICH regions: the Basket Apparatus (Apparatus 1), the Paddle Apparatus (Apparatus 2) and the Flow-Through Cell.
There also have been updates of the considerations for implementation for the FDA, the European Union and the competent authority Japan (MHLW).
One of the FDA's specific remark concerns the fact that the mechanical calibration of apparatuses for Dissolution Testing which had been proposed in the past by the FDA is sufficient to comply with the CGMP requirements concerning calibration of dissolution apparatuses. The Document on mechanical calibration can be found
here.Please also see the complete
ICH Q4B - Annex 7(R2) for further information.The ECA Education Course "Dissolution Testing" in Berlin, Germany, from 2-4 November 2011 will give an excellent overview of the current pharmacopoeial requirements. The highlight of the programme
will be the visit of the dissolution robots in the Bayer HealthCare Pharmaceuticals Laboratories in Berlin.Author:
Günter Brendelberger
CONCEPT HEIDELBERG (a service provider entrusted by the ECA Foundation)
Related GMP News
14.07.2025Inadequate Sampling and Component Testing Highlighted in FDA Warning Letter
14.07.2025EMA publishes new Product-Specific Bioequivalence Guidance
14.07.2025Revision of USP Chapter <1039> Chemometrics Published for Comments
14.07.2025Proposal for new USP Chapter <318> NMR Monomer Ratio Determination for Lactide-Glycolide Polymers
14.07.2025New USP Chapter <1221> on Ongoing Procedure Performance Verification (OPPV) Published for Comment
02.07.2025FDA Warning Letter: Missing Testing, No Stability Data, and Inadequate Raw Material Controls